/MRRCF

MRRCF Stock - Wayland Group Corp.

Q: What is the analyst price target for MRRCF?

Analyst price target information is not currently available for MRRCF.

Q: What is MRRCF's market cap?

Market capitalization information is not currently available for MRRCF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MRRCF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2015

FY2016

FY2017

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-44.34

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2017	FY2016	FY2015
Revenue	$2.48M	$3.06M	N/A
Gross Profit	$-3,845,141	$-1,391,313	N/A
Gross Margin	-154.9%	-45.4%	N/A
Operating Income	$-21,319,830	$-5,704,750	$-42,550
Net Income	$-51,627,389	$-6,261,326	$-72,642.452
Net Margin	-2079.4%	-204.3%	N/A
EPS	$-0.75	$-0.17	$-0.01

Company Overview

Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.

Visit Website

Earnings History & Surprises

MRRCF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2018	Nov 28, 2018	—	—	—	—
Q3 2018	Aug 24, 2018	—	—	—	—
Q2 2018	May 29, 2018	—	—	—	—
Q2 2018	Apr 27, 2018	—	—	—	—
Q4 2017	Nov 28, 2017	—	—	—	—
Q3 2017	Aug 29, 2017	—	—	—	—
Q2 2017	May 30, 2017	—	—	—	—
Q2 2017	May 10, 2017	—	—	—	—

Frequently Asked Questions about MRRCF

What is MRRCF's current stock price?

Wayland Group Corp. (MRRCF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for MRRCF?

No analyst price targets are currently available for this stock.

What sector is Wayland Group Corp. in?

Wayland Group Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is MRRCF's market cap?

Wayland Group Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does MRRCF pay dividends?

No, Wayland Group Corp. does not currently pay a dividend to shareholders.